On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
Our narrow economic moat rating for UnitedHealth Group reflects our generally narrow-moat view of the US health insurance and PBM industries that includes an unclear outlook for economic profitability ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
UnitedHealth's CEO acknowledged discontent with the health care system, but quickly shifted the blame elsewhere.
Operator Good morning and welcome to the UnitedHealth Group fourth quarter and full year 2024 earnings conference call. A ...
The company is at a pivotal point following the killing of Brian Thompson, who headed the UnitedHealthcare unit, and there was a public outcry about insurance denials. That prompted Andrew Witty, the ...
KARK Little Rock on MSN2h
Bill before Arkansas legislature would restrict pharmacy benefit managersA bill before the Arkansas legislature would prevent pharmacy benefit managers (PBMs) or insurance companies from obtaining ...
Biosimilar launches achieve a 53% market share and a 53% reduction in average drug costs after 5 years of biosimilar ...
Adjusted per-share earnings in the fourth quarter for UnitedHealth top analysts’ estimates but revenue comes up short.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback